These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3423101)

  • 1. Effect of nisoldipine on de-endothelialized large coronary artery in isolated working rabbit hearts.
    Saeed M; Hartmann A; Bing RJ
    Pharmacology; 1987; 35(5):256-63. PubMed ID: 3423101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nisoldipine as a vasodilator in endothelium-deprived large coronary arteries of isolated working rabbit hearts.
    Saeed M; Hartmann A; Bing RJ
    Eur Heart J; 1989 Nov; 10 Suppl F():159-63. PubMed ID: 2620683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nisoldipine on large coronary arteries in situ: inhibition of vasoconstriction induced by vasopressin.
    Saito T; Saeed M; Bing RJ
    Pharmacology; 1988; 37(2):85-93. PubMed ID: 3212040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nisoldipine on coronary resistance, contractility and oxygen consumption of the isolated blood-perfused canine left ventricle.
    Schipke JD; Burkhoff D; Alexander J; Schaefer J; Sagawa K
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1000-4. PubMed ID: 3252017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 8-bromo-cyclic guanosine monophosphate (cGMP) on coronary artery constriction in isolated rabbit hearts.
    Bing RJ; Saeed M
    J Am Coll Cardiol; 1986 Aug; 8(2):342-8. PubMed ID: 3016062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute coronary hemodynamic effects of equihypotensive doses of nisoldipine and diltiazem.
    Suryapranata H; Serruys PW; Soward AL; Planellas J; Vanhaleweyk G; Hugenholtz PG
    Aust N Z J Med; 1985 Dec; 15(6):685-90. PubMed ID: 3869435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of leukotriene actions by the calcium channel blocker, nisoldipine.
    Lefer AM; Yanagisawa A
    Proc Soc Exp Biol Med; 1986 Jul; 182(3):296-300. PubMed ID: 3012574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of calcium antagonist darodipine on the isolated human heart.
    Ginsburg R; Carey B; Zera P
    Eur J Pharmacol; 1986 Jun; 125(2):287-91. PubMed ID: 3743638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model for the study of coronary spasm induced changes in cardiac metabolism.
    Burger W; Chemnitius JM; Metz MZ; Bing RJ
    J Mol Cell Cardiol; 1985 Sep; 17(9):917-30. PubMed ID: 4046051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular profiles of the calcium antagonists nisoldipine and nifedipine in the blood-perfused dog heart.
    Takahashi K; Taira N
    Arzneimittelforschung; 1986 Jul; 36(7):1054-9. PubMed ID: 3768072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of nisoldipine on the oxymyoglobin level of myocardial cells in hypoxic, perfused rat hearts.
    Hara A; Matsumura H; Abiko Y
    Arch Int Pharmacodyn Ther; 1989; 298():78-89. PubMed ID: 2757469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nisoldipine and perfusion of post-stenotic myocardium in conscious pigs with different degrees of concentric stenosis.
    Duncker DJ; Heiligers JP; Saxena PR; Verdouw PD
    Br J Pharmacol; 1988 May; 94(1):219-27. PubMed ID: 3401639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectivity scale of calcium antagonists in the human cardiovascular system based on in vitro studies.
    Godfraind T; Salomone S; Dessy C; Verhelst B; Dion R; Schoevaerts JC
    J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S34-41. PubMed ID: 1282611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic and antiischemic effects of nifedipine, lacidipine, and nisoldipine in rat isolated working heart.
    Pijl AJ; Pfaffendorf M; van Zwieten PA
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):381-7. PubMed ID: 7504127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfused rabbit heart: endothelium-derived relaxing factor in coronary arteries.
    Saeed M; Schmidli J; Metz M; Bing RJ
    J Cardiovasc Pharmacol; 1986; 8(2):257-61. PubMed ID: 2422462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary and systemic hemodynamic effects of intravenous nisoldipine.
    Soward AL; De Feyter PJ; Hugenholtz PG; Serruys PW
    Am J Cardiol; 1986 Dec; 58(13):1199-203. PubMed ID: 2878602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of vasodilating effects of nisoldipine and nifedipine in anesthetized open-chest dogs.
    Sakanashi M; Noguchi K; Kato T; Sunagawa R; Nagamine F; Nakasone J
    Arzneimittelforschung; 1986 Dec; 36(12):1736-9. PubMed ID: 3566835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nisoldipine on coronary collateral perfusion and hemodynamics in chronically instrumented dogs.
    Kenny D; Hartman JC; Brooks HL; Warltier DC
    Pharmacology; 1989; 38(4):263-71. PubMed ID: 2755966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of efonidipine hydrochloride (NZ-105), a dihydropyridine derivative with calcium antagonistic action, on myocardial oxygen tension in anesthetized dogs].
    Fujikura N; Yokoyama T; Masuda Y; Shikada K; Tanaka S
    Nihon Yakurigaku Zasshi; 1996 Nov; 108(5):267-74. PubMed ID: 8974087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-related effects of intracoronary application of nisoldipine on central and peripheral circulatory parameters.
    Schartl M; Heidelmeyer C; Veit S; Dougherty C; Brückner JB
    Arzneimittelforschung; 1989 Jun; 39(6):682-5. PubMed ID: 2775335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.